BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Staging
6 results:

  • 1. Prognoses of Patients Treated With Surgical Therapy Versus Continuation of Local-Plus-Systemic Therapy Following Successful Down-staging of Intermediate-Advanced Hepatocellular Carcinoma: A Multicenter Real-World Study.
    Liu J; Zhu X; Pan Y; Zhong J; Jin R; Zheng X; Zhang W; Hu K; Ma J; Shi X; Liu H; Yang X; Xu D; Ma C; Chen J; Wang D; Wang X; Li Z; Zhao L; Zhang L; Li T; Liu F; Tan G; Xing B; Zhao H; Zeng Y; Zhang S; Zhang L; Zhou L; Song T; Yang W; Liang X; Xiang B; Xu L; Sun H; Wang K
    Oncologist; 2024 Apr; 29(4):e487-e497. PubMed ID: 37874924
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Magnetic Resonance Imaging Radiomics-Based Nomogram From Primary Tumor for Pretreatment Prediction of Peripancreatic Lymph Node Metastasis in pancreatic Ductal Adenocarcinoma: A Multicenter Study.
    Shi Z; Ma C; Huang X; Cao D
    J Magn Reson Imaging; 2022 Mar; 55(3):823-839. PubMed ID: 34997795
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Original study: The rescue staging for pancreatic ductal adenocarcinoma with inadequate examined lymph nodes.
    Fu N; Wang W; Cheng D; Wang J; Xu Z; Deng X; Peng C; Chen H; Shen B
    Pancreatology; 2021 Jun; 21(4):724-730. PubMed ID: 33642141
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Development and Validation of a Nomogram for Predicting Survival in Patients with Advanced pancreatic Ductal Adenocarcinoma.
    Deng QL; Dong S; Wang L; Zhang CY; Ying HF; Li ZS; Shen XH; Guo YB; Meng ZQ; Yu JM; Chen QW
    Sci Rep; 2017 Sep; 7(1):11524. PubMed ID: 28912447
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Validation of the 6th edition AJCC pancreatic cancer staging System: report from the National cancer Database.
    Bilimoria KY; Bentrem DJ; Ko CY; Ritchey J; Stewart AK; Winchester DP; Talamonti MS
    Cancer; 2007 Aug; 110(4):738-44. PubMed ID: 17580363
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Evaluation of a serologic marker, CA19-9, in the diagnosis of pancreatic cancer.
    Pleskow DK; Berger HJ; Gyves J; Allen E; McLean A; Podolsky DK
    Ann Intern Med; 1989 May; 110(9):704-9. PubMed ID: 2930108
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.